Junyuan Lv

405 total citations
23 papers, 303 citations indexed

About

Junyuan Lv is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junyuan Lv has authored 23 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 11 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junyuan Lv's work include Breast Cancer Treatment Studies (5 papers), Cancer-related molecular mechanisms research (5 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). Junyuan Lv is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cancer-related molecular mechanisms research (5 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). Junyuan Lv collaborates with scholars based in China. Junyuan Lv's co-authors include Shijie Xin, Lun Wang, Dong Yang, Lin Zhao, Yeli Li, Danli Yang, Yuting Wu, Jing Zhang, Yun Yue and Taolang Li and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Pharmacology and Frontiers in Physiology.

In The Last Decade

Junyuan Lv

22 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyuan Lv China 11 143 131 65 57 37 23 303
Yaling Bai China 12 218 1.5× 150 1.1× 31 0.5× 60 1.1× 30 0.8× 50 428
Tania Tsatralis Australia 10 191 1.3× 79 0.6× 52 0.8× 34 0.6× 38 1.0× 11 335
Serena Contarelli Italy 11 194 1.4× 68 0.5× 40 0.6× 55 1.0× 43 1.2× 12 336
Xiaofeng Zou China 12 304 2.1× 153 1.2× 56 0.9× 77 1.4× 14 0.4× 42 447
Xiaozhou Zou China 11 200 1.4× 124 0.9× 32 0.5× 122 2.1× 27 0.7× 19 372
Tonglie Huang China 10 184 1.3× 124 0.9× 61 0.9× 27 0.5× 38 1.0× 12 398
Mingxing Qiu China 11 158 1.1× 123 0.9× 61 0.9× 75 1.3× 16 0.4× 29 362
Zhenming Zhang China 9 206 1.4× 150 1.1× 60 0.9× 33 0.6× 9 0.2× 32 338
Xiaofei Yang China 11 178 1.2× 79 0.6× 84 1.3× 22 0.4× 17 0.5× 37 345

Countries citing papers authored by Junyuan Lv

Since Specialization
Citations

This map shows the geographic impact of Junyuan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyuan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyuan Lv more than expected).

Fields of papers citing papers by Junyuan Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyuan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyuan Lv. The network helps show where Junyuan Lv may publish in the future.

Co-authorship network of co-authors of Junyuan Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Junyuan Lv. A scholar is included among the top collaborators of Junyuan Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyuan Lv. Junyuan Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jiayang, Yuxiang Bao, Zhongliang Yan, et al.. (2024). Chemotherapy combined with endocrine neoadjuvant therapy for hormone receptor-positive local advanced breast cancer: a case report and literature review. Frontiers in Endocrinology. 15. 1362725–1362725. 1 indexed citations
2.
Li, Jiayang, et al.. (2024). Ferroptosis in the adjuvant treatment of lung cancer-the potential of selected botanical drugs and isolated metabolites. Frontiers in Pharmacology. 15. 1430561–1430561.
3.
Yan, Zhongliang, Yuxiang Bao, Jiayang Li, et al.. (2024). Detection of thyroglobulin for diagnosis of metastatic lateral cervical lymph nodes in papillary thyroid carcinoma: accuracy and application in clinical practice. Translational Cancer Research. 13(2). 1043–1051. 1 indexed citations
4.
Bao, Yuxiang, Zhongliang Yan, Xiao‐Yan Tian, et al.. (2024). LCN2: Versatile players in breast cancer. Biomedicine & Pharmacotherapy. 171. 116091–116091. 12 indexed citations
5.
Li, Jiayang, Yuxiang Bao, Zhongliang Yan, et al.. (2024). Chemotherapy Combined With Endocrine Therapy: Old Wine in a New Bottle?. Clinical Breast Cancer. 24(8). e737–e747. 1 indexed citations
6.
Bao, Yuxiang, et al.. (2023). Isolated soft tissue tuberculosis: a case report and literature review. Frontiers in Medicine. 10. 1205446–1205446. 1 indexed citations
7.
Jiang, Yan, Jiayang Li, Baolin Chen, et al.. (2022). Sentinel Lymph Node Biopsy Mapped With Carbon Nanoparticle Suspensions in Patients With Breast Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 12. 818812–818812. 11 indexed citations
8.
Li, Xintong, et al.. (2022). Therapeutic efficacy of mesenchymal stem cells for abdominal aortic aneurysm: a meta-analysis of preclinical studies. Stem Cell Research & Therapy. 13(1). 81–81. 9 indexed citations
9.
Lv, Junyuan, Xintong Li, Hongyu Wu, et al.. (2022). Icariside II Restores Vascular Smooth Muscle Cell Contractile Phenotype by Enhancing the Focal Adhesion Signaling Pathway in the Rat Vascular Remodeling Model. Frontiers in Pharmacology. 13. 897615–897615. 5 indexed citations
10.
Chen, Baolin, Yan Jiang, Yuxiang Bao, et al.. (2022). Significant efficacy of paclitaxel plus carboplatin (TP) as a neoadjuvant regimen for metaplastic squamous cell carcinoma of the breast: a rare case report and literature review. Translational Cancer Research. 11(8). 2953–2959. 3 indexed citations
11.
Lv, Junyuan, Lei Wang, Xuan Li, et al.. (2021). Potential Target miR-455 Delaying Arterial Stenosis Progression Through PTEN. Frontiers in Cardiovascular Medicine. 8. 611116–611116. 5 indexed citations
12.
13.
Li, Taolang, Zhiyuan Ma, Hu Wang, et al.. (2020). Application of carbon nanoparticles combined with intraoperative neuromonitoring in papillary thyroid microcarcinoma surgery. American Journal of Otolaryngology. 42(1). 102790–102790. 5 indexed citations
14.
Huang, Liangliang, Yi Luo, Junyuan Lv, et al.. (2019). <p>JAZF1 Suppresses Papillary Thyroid Carcinoma Cell Proliferation and Facilitates Apoptosis via Regulating TAK1/NF-κB Pathways</p>. OncoTargets and Therapy. Volume 12. 10501–10514. 15 indexed citations
15.
Yue, Yun, Yiqi Li, Yuting Wu, et al.. (2019). Osthole inhibits cell proliferation by regulating the TGF-β1/Smad/p38 signaling pathways in pulmonary arterial smooth muscle cells. Biomedicine & Pharmacotherapy. 121. 109640–109640. 30 indexed citations
16.
Lv, Junyuan, et al.. (2018). Long noncoding RNA H19 promotes vascular remodeling by sponging let-7a to upregulate the expression of cyclin D1. Biochemical and Biophysical Research Communications. 508(4). 1038–1042. 25 indexed citations
17.
18.
Lv, Junyuan, et al.. (2017). Long noncoding RNA H19-derived miR-675 aggravates restenosis by targeting PTEN. Biochemical and Biophysical Research Communications. 497(4). 1154–1161. 55 indexed citations
19.
20.
Yang, Dong, Chen Sun, Jing Zhang, et al.. (2017). Proliferation of vascular smooth muscle cells under inflammation is regulated by NF-κB p65/microRNA-17/RB pathway activation. International Journal of Molecular Medicine. 41(1). 43–50. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaling Bai Breakdown of academic impact, for papers by Tania Tsatralis Breakdown of academic impact, for papers by Serena Contarelli Breakdown of academic impact, for papers by Xiaofeng Zou Breakdown of academic impact, for papers by Xiaozhou Zou Breakdown of academic impact, for papers by Tonglie Huang Breakdown of academic impact, for papers by Mingxing Qiu Breakdown of academic impact, for papers by Zhenming Zhang Breakdown of academic impact, for papers by Xiaofei Yang
Rankless by CCL
2026